TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) has provided an announcement.
Shanghai Pharmaceuticals Holding Co., Ltd. has announced an interim cash dividend of RMB 1.2 per 10 shares for the six months ending June 30, 2025. This update includes the date for shareholders’ approval set for December 9, 2025, but other details such as the payment date and exchange rate remain to be announced, reflecting the company’s ongoing commitment to shareholder returns.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$13.00 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is a significant player in the Chinese market, offering a diverse range of healthcare solutions.
Average Trading Volume: 3,317,118
Technical Sentiment Signal: Buy
Current Market Cap: HK$67.18B
See more data about 2607 stock on TipRanks’ Stock Analysis page.